Sean Dickson is an officer with Pew’s drug spending research initiative, studying the underlying drivers of rising drug costs and identifying policy options that limit spending growth. His research considers the role of government regulations and incentives on pharmaceutical markets, highlighting ways public and private payers can manage their drug spending.
Dickson joined Pew after working for both pharmaceutical manufacturers and state governments on issues related to drug pricing, development, and access. During his time in the pharmaceutical industry, Dickson counseled manufacturers on compliance with federal drug price reporting requirements. He subsequently supported state public health departments in discount negotiations with drug manufacturers and advising on compliance with federal drug discount program requirements.
He received a law degree and a master’s degree in public health from the University of Michigan, and a bachelor’s degree in public policy from the University of Chicago.